Clinical Trial Update: Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer [NA]

View source ↗

Summary

A trial evaluating whether a genomic test influences shared decisions on adjuvant chemotherapy for ER-positive, HER2-negative early breast cancer has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNICANCER | Conditions: ER-positive Her2-negative Early Breast Cancer | NA | Status: WITHDRAWN